Mineralys Therapeutics, Inc.MLYSNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P0
Near historical low
vs 3Y Ago
-0.4x
Contraction
Streak
2 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | -21.69% |
| 2024 | 139.59% |
| 2023 | 168.04% |
| 2022 | 60.96% |
| 2021 | 576.40% |
| 2020 | 0.00% |